Aratana builds pet drug pipeline by buying rights from Japanese company
March 02, 2018 at 15:46 PM EST
Aratana Therapeutics purchased exclusive rights to a pain treatment from Japanese drug developer AskAt Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.